Fenestrel
Fenestrel (INN, USAN) (developmental code name ORF-3858) is a synthetic, nonsteroidal estrogen that was developed as a postcoital contraceptive in the 1960s but was never marketed. Synthesized by Ortho Pharmaceutical in 1961 and studied extensively, it was coined the "morning-after-pill" or "postcoital antifertility agent". Fenestrel is a seco analogue of doisynolic acid, and a member of the series of estrogens.
differentFrom
primaryTopic
Fenestrel
Fenestrel (INN, USAN) (developmental code name ORF-3858) is a synthetic, nonsteroidal estrogen that was developed as a postcoital contraceptive in the 1960s but was never marketed. Synthesized by Ortho Pharmaceutical in 1961 and studied extensively, it was coined the "morning-after-pill" or "postcoital antifertility agent". Fenestrel is a seco analogue of doisynolic acid, and a member of the series of estrogens.
has abstract
Fenestrel (INN, USAN) (develop ...... er of the series of estrogens.
@en
CAS number
FDA UNII code
LEC4215V9R
PubChem
Wikipage page ID
48,988,115
page length (characters) of wiki page
Wikipage revision ID
1,001,212,202
Link from a Wikipage to another Wikipage
ATC prefix
None
@en
CAS number
ChemSpiderID
IUPAC name
PubChem
SMILES
CCC1CC
@en
StdInChIKey
CLMFEXDZPBGYQQ-UHFFFAOYSA-N
@en
synonyms
Demethoxycarbestrol; NSC-86465; 2-methyl-3-ethyl-4-phenyl-δ4-cyclohexenecarboxylic acid
@en
UNII
LEC4215V9R
@en
wikiPageUsesTemplate
hypernym
comment
Fenestrel (INN, USAN) (develop ...... er of the series of estrogens.
@en
label
Fenestrel
@en